fbpx

Efficacy of Cannabinoids in a Pre-Clinical Drug-Screening Platform for Alzheimer’s Disease

Penicillin celebrated its 90th anniversary last year. The story of the mold extract’s accidental discovery is legendary, taught in schools and touted in labs. In 1890, acetylsalicylic acid, commonly known as Aspirin, was synthetically modeled after its naturally occurring counterpart found in such common plants as birch, wintergreen, and willow. Medicine has benefited from nature […]

Ep. 459: Dr. Ethan Russo

Dr. Ethan Russo, Research Director of the International Cannabis and Cannabinoids Institute (ICCI), discusses ways to create a better, safer cannabis. Russo points out the dissonance that exists between public opinion and regulators – while 80-90% of the public already believes that cannabis is a medicine, the medical community must conduct clinical trials in order […]

Ep. 453: Don Fertman

Another great conversation with Don Fertman as he shares stories about his past struggles with alcohol addiction, providing a framework to talk about cannabis, addiction, and moderation: “I got myself together and got myself to work, but now I felt like even more of a failure. My self-loathing, my self-hatred, my sense of disgust with […]

Ep. 448: Charlie Bachtell, Cresco Labs

Charlie Bachtell joins us and shares how Cresco Labs and other medical cannabis providers have to adapt to pass regulation audits: “The objectives of the state are to make sure that you are tracking everything from seed to sale, that you are putting out as consistent and safe of a product as you, possibly, can, […]

Chronic Pain

Cannabis’ current regulation in the United States, as well as around the world, limits the vast research needed to educate the public about its advantages.

Ep. 435: Bridget Conry, Champlain Valley Dispensary

At root, Bridget Conry is an herbalist with a steadfast faith in the power of plants. Besides believing that everyone should be able to grow their own medicine, Conry also discusses the importance and efficacy of educating people about cannabis in a patient and professional manner. She also notes that communities will likely gain more […]

Human-made Marijuana

Human interest in cannabis began thousands of years ago. The origin of cannabis is not entirely certain. The earlier records for this species…

Ep. 432: Dr. Michael Segal, Shaar Menashe Hospital

For eleven years, Dr. Michael Segal has been treating PTSD patients – mainly IDF veterans – with medical cannabis. Segal describes the incredible improvements he has seen in his patients: “If you see a post-traumatic patient before and after cannabis, you see two different persons.” Segal compares this type of success in Israel to the […]

EP. 431: Dr. Silviu Brill, Tel Aviv Medical Center

Dr. Silviu Brill, of the Pain Institute of Tel Aviv Medical Center, is passionate about the need for personalized medicine in Israel and around the world. Although he believes that some standardization is necessary, it is indisputable that each person and condition requires a unique ratio of THC and CBD. As Honorary Secretary of the […]

Ep. 429: Professor Gil Bar Sela, Rambam Academic Hospital

Professor Gil Bar-Sela joins us and explains how cannabis is used to treat different illnesses and conditions: “For example, if we want to bring cannabis as cancer treatment, then of course, we need to do a specific study trying to answer this indication like every medicine that goes into the market. If you are dealing […]